Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2026 08h30 HE | Source: BiomX

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it has completed the acquisition of 100% of Zorronet...
10 avr. 2026 08h30 HE | Source: Nilörngruppen AB

Kallelse till Årsstämma

Aktieägarna i Nilörngruppen AB (publ.), 556322-3782, kallas härmed till årsstämma måndag den 11 maj kl. 15.00 på Wieslanders väg 3, 504 13 Borås ANMÄLANAktieägare som önskar delta i årsstämman ska: ...
10 avr. 2026 08h30 HE | Source: Nilörngruppen AB

Notice of General Meeting

Aktieägarna i Nilörngruppen AB (publ.), 556322-3782, kallas härmed till årsstämma måndag den 11 maj kl. 15.00 på Wieslanders väg 3, 504 13 Borås ANMÄLANAktieägare som önskar delta i årsstämman ska: ...
10 avr. 2026 08h30 HE | Source: FibroBiologics, Inc.

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

HOUSTON, April 10, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with...
10 avr. 2026 08h30 HE | Source: Annovis Bio Inc.

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...
10 avr. 2026 08h15 HE | Source: BCC Research LLC

Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate

Report provides in-depth insights into technological developments, pipeline trends, and global opportunities shaping the future of bispecific antibodies.
10 avr. 2026 08h15 HE | Source: BitFuFu Inc.

BitFuFu Announces March 2026 Bitcoin Production and Operational Updates

BitFuFu reports 214 BTC produced and 1,794 BTC held in March 2026, with 25.9 EH/s total hashrate under management.
10 avr. 2026 08h03 HE | Source: Aalborg Boldspilklub A/S

Storaktionærmeddelelse

NASDAQ Copenhagen A/S Børsmeddelelse nr. 2026/13 Aalborg, 10. april 2026 I henhold til §38 i Lov om kapitalmarkeder skal det hermed oplyses, at Nordic Football Group (Sports Strategy Excellence...
10 avr. 2026 08h00 HE | Source: Air Canada

Air Canada Expands Premium Airport Experience with New Café Openings in Montréal and Vancouver

Second Air Canada Café at Vancouver’s domestic C concourse offers an expanded, 84-seat premium space, inspired by West Coast design and culinary cultureNew 62-seat Air Canada Café at in...
10 avr. 2026 07h48 HE | Source: Aalborg Boldspilklub A/S

Offentliggørelse af fritagelsesdokument

NASDAQ Copenhagen A/S Børsmeddelelse nr. 2026/12 Aalborg, 10. april 2026 I forlængelse af børsmeddelelse 2026/09 ”Kapitalforhøjelse som følge af udnyttelse af Warrant 2” og børsmeddelelse...

Page précédente

Page suivante